| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/23/2008 | CN101224188A Compound sustained release injection containing newborn blood vessel inhibitor marimastat |
| 07/23/2008 | CN101224187A Dual functional polymer nanometer glue bunch and preparing method and application in preparing medicine for treating second narrow blood vessel |
| 07/23/2008 | CN101224185A Bosutinib sustained release implant for treating solid tumors |
| 07/23/2008 | CN100404673C Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 07/23/2008 | CN100404073C Method for preparing hard-soluble gel formulation |
| 07/23/2008 | CN100404072C Extended, controlled-release pharmaceutical compositions using charged polymers |
| 07/23/2008 | CN100404071C Medicinal composition |
| 07/23/2008 | CN100404068C Injection solution comprising an LHRH antagonist |
| 07/23/2008 | CN100404032C Novel crystalline forms of the anti-cancer compound ZD1839 |
| 07/23/2008 | CN100404022C Adhesive composition for dermal patch and production process thereof |
| 07/23/2008 | CN100404021C Medical super fire micro capsule capsaicine and its preparing method |
| 07/23/2008 | CN100404019C Multivesicular emulsion topical delivery systems |
| 07/23/2008 | CN100404014C A capsule filling machine |
| 07/22/2008 | US7402662 Antibody molecules specific to human tumor necrosis factor alpha |
| 07/22/2008 | US7402657 C-C chemokine receptor 3 proteins |
| 07/22/2008 | US7402609 Olopatadine formulations for topical administration |
| 07/22/2008 | US7402593 (-)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]imidazo[4,5-b]pyridine; proton pump inhibitor (PPI) to treat gastro-oesophageal reflux, digestive bleeding and dyspepsia; enantiomer; long duration of action; longer half-life in plasma; oxidation of sulfide followed by salt formation |
| 07/22/2008 | US7402591 Analgesic compositions containing buprenorphine |
| 07/22/2008 | US7402572 Suppressing a symptom of an allergic response using nucleic acids containing unmethylated CpG dinucleotides |
| 07/22/2008 | US7402556 Prodrugs activated by plasmin and their use in cancer chemotherapy |
| 07/22/2008 | US7402401 Determining whether ST receptor protein or mRNA encoding it is present in lymph node; polymerase chain reaction and binding assay |
| 07/22/2008 | US7402321 Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles |
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2584456C Composition comprising desmopressin |
| 07/22/2008 | CA2457056C Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastasis or preventing the recurrence of malignant tumor |
| 07/22/2008 | CA2430481C Compositions for sustained delivery of hydrophobic drugs and process for the preparation thereof |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/22/2008 | CA2282706C Adenovirus vectors specific for cells expressing .alpha.-fetoprotein and methods of use thereof |
| 07/22/2008 | CA2278328C Antifungal nail lacquer and method using same |
| 07/22/2008 | CA2244205C Methods and compositions for enhancing the bioadhesive properties of polymers |
| 07/22/2008 | CA2222544C Site specific binding system, imaging compositions and methods |
| 07/22/2008 | CA2198916C Delivery of solid drug compositions |
| 07/22/2008 | CA2196801C Novel vaccine adjuvant and vaccine |
| 07/17/2008 | WO2008086330A2 Formulations of deacetylase inhibitors |
| 07/17/2008 | WO2008086176A2 Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease |
| 07/17/2008 | WO2008084823A1 Brown coating composition and method for preparation thereof |
| 07/17/2008 | WO2008084805A1 Composition for external use |
| 07/17/2008 | WO2008084698A1 Tacrolimus sustained release pharmaceutical composition |
| 07/17/2008 | WO2008084676A1 Pharmaceutical composition comprising porous dry matrix |
| 07/17/2008 | WO2008084237A2 Stabilization of aqueous compositions of proteins with displacement buffers |
| 07/17/2008 | WO2008083678A2 Pharmaceutically active compounds |
| 07/17/2008 | WO2008083615A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof |
| 07/17/2008 | WO2008083561A1 Oral pharmaceutical composition of glycyrrhizin or its salts and the preparation method thereof |
| 07/17/2008 | WO2008064815A3 Preparation for transdermally administering galanthamine |
| 07/17/2008 | WO2008053479A9 Self-immolative polymers |
| 07/17/2008 | WO2008052187A3 Antibodies and immunoconjugates and uses therefor |
| 07/17/2008 | WO2008043167A8 Pharmaceutical compositions comprising intra- and extra- granular fractions |
| 07/17/2008 | WO2007116409A3 Improved vaccines comprising multimeric hsp60 peptide carriers |
| 07/17/2008 | US20080172014 Extended therapeutic effect ocular implant treatments |
| 07/17/2008 | US20080171862 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 07/17/2008 | US20080171861 Method and medicament for inhibiting the expression of a given gene |
| 07/17/2008 | US20080171729 For an antiinflammatory agent, antiacne agent, antiproliferative agent, antiphototoxic agent, anti-hair loss agent, analgesic, antiaging agent, antiperspirant, antipruritic, astringent, or microbiocide; calcineurin inhibitors |
| 07/17/2008 | US20080171363 Interferon-alpha polypeptides and conjugates |
| 07/17/2008 | US20080171088 Particles of megestrol, megestrol acetate and a surface stabilizer |
| 07/17/2008 | US20080171083 Pharmaceutical Compositions Comprising an Amphiphilic Starch |
| 07/17/2008 | US20080171073 Antibiotic-Sensitive Lactic Acid Bacteria Strains |
| 07/17/2008 | US20080171067 Polymeric Carriers of Therapeutic Agents and Recognition Moieties for Antibody-Based Targeting of Disease Sites |
| 07/17/2008 | US20080171040 Antibody-drug conjugates and methods |
| 07/17/2008 | US20080170997 Compositions for the treatment and prevention of cancer |
| 07/17/2008 | DE60130743T2 Mikrokugeln zur aktiven embolisierung Microspheres for embolization active |
| 07/17/2008 | DE202006020168U1 Pharmazeutische Formulierung für die Herstellung von schnell zerfallenden Tabletten A pharmaceutical formulation for the manufacture of rapidly disintegrating tablets |
| 07/17/2008 | DE112006002419T5 Verfahren zur Herstellung von optisch aktivem α-Ionen A process for producing optically active α-ion |
| 07/17/2008 | CA2694431A1 Conducting polymer nanotube actuators for precisely controlled release of medicine and bioactive molecules |
| 07/17/2008 | CA2675231A1 A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof |
| 07/17/2008 | CA2675029A1 Pharmaceutically active compounds |
| 07/17/2008 | CA2674608A1 Anti-il-13 antibody formulations and uses thereof |
| 07/17/2008 | CA2674604A1 Formulations of deacetylase inhibitors |
| 07/17/2008 | CA2674228A1 Modified saccharides |
| 07/17/2008 | CA2674039A1 Sustained release formulation for tacrolimus |
| 07/16/2008 | EP1944354A1 Flavor composition or fragrance composition, and flavor-improving agent |
| 07/16/2008 | EP1944312A1 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 07/16/2008 | EP1944058A1 Iontophoresis apparatus sticking to mucosa |
| 07/16/2008 | EP1944043A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 07/16/2008 | EP1944032A2 Biodegradable intraocular implants containing prostamides |
| 07/16/2008 | EP1944029A1 Pharmaceutical preparation having excellent photostability |
| 07/16/2008 | EP1944019A2 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 07/16/2008 | EP1943305A2 Processing of chitosan and chitosan derivatives |
| 07/16/2008 | EP1943013A1 Oil- n-water emulsions |
| 07/16/2008 | EP1942944A2 Macrocyclic depsipeptide antibody-drug conjugates and methods |
| 07/16/2008 | EP1942943A2 Peptide-dicer substrate rna conjugates as delivery vehicles for sirna |
| 07/16/2008 | EP1942942A2 Polysaccharide-derived nitric oxide-releasing carbon-bound diazeniumdiolates |
| 07/16/2008 | EP1942940A2 Use of sdf-1 for the treatment and/or prevention of neurological diseases |
| 07/16/2008 | EP1942939A2 Interleukin-13 antibody composition |
| 07/16/2008 | EP1942912A1 Agent for applying to mucosa and method for production thereof |
| 07/16/2008 | EP1942872A2 Carboxyalkylcellulose esters for administration of poorly soluble pharmaceutically active agents |
| 07/16/2008 | EP1942868A2 Sodium chloride solution for drug reconstitution or dilution |
| 07/16/2008 | EP1554316B1 Lignan complexes |
| 07/16/2008 | EP1534245B1 Rapidly disintegrating tablet |
| 07/16/2008 | EP1492500B1 Formoterol and ciclesonide aerosol formulations |
| 07/16/2008 | EP1446104B1 Spray drying methods |
| 07/16/2008 | EP1392264B1 Delivery of antiemetics through an inhalation route |
| 07/16/2008 | EP1392257B1 Delivery of antihistamines through an inhalation route |
| 07/16/2008 | EP1337270B1 Long-acting interferon and interlukin derivatives and pharmaceutical compositions comprising them |
| 07/16/2008 | EP1305006B1 Process for the manufacture of dispersions for formulating slightly or poorly soluble active ingredients |
| 07/16/2008 | EP1296655B1 Endoparasiticidal agents for voluntary oral ingestion by animals |
| 07/16/2008 | EP1180123B1 Immunoconjugates having high binding affinity |
| 07/16/2008 | EP1163012B1 A kit of parts for use in inhibiting the formation of endoleaks associated with endovascular repair of abdominal aortic aneurysms |
| 07/16/2008 | EP0840599B1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 07/16/2008 | EP0748377B1 IMPROVED DNase LIQUID SOLUTIONS |
| 07/16/2008 | CN101222942A Peptides for use in the treatment of obesity |